For some, this may be a bit too hands-off
international peers): $25.0B/year Issue #3 : Hospital Commercial Reference Pricing: $73.0B/year Issue #4 : PBM Reform: $30.0B/year Issue #5 : Administrative Waste (hospital operational variance, multi-payer billing complexity, prior authorization): $200.0B/year Issue #6 : Hospital Supply Waste (within-peer operational variance, case-mix adjusted): $28.0B/year Issue #7 : GLP-1 Pricing (price reduction opportunity from US-international alignment + generic entry): $40.0B/year Running total: $396.6 billion per year, 13.2% of the $3 trillion annual gap between US and Japanese per-capita healthcare spending
ParlevlietETHeijboerACSchroder-van der ElstJPHavekesLMRomijnJAPijlHet al
Instead, their plausible contribution is indirect: by improving insulin sensitivity, reducing chronic low-grade inflammation, and supporting metabolic flexibility, postbiotics may enhance the efficiency of nutrient utilization and the anabolic response to protein and exercise
Researchers followed 173 patients with rheumatoid arthritis and a BMI of at least 27 who took semaglutide or tirzepatide, compared with 42 who were prescribed the medication but never started it
